Terbequinil

Summary

Terbequinil (SR-25776) is a stimulant and nootropic drug which acts as a partial inverse agonist at benzodiazepine sites on the GABAA receptor. In human trials it was found to partially reverse the sedative and amnestic effects of the hypnotic drug triazolam with only slight effects when administered by itself.[1]

Terbequinil
Ball-and-stick model of the terbequinil molecule
Clinical data
ATC code
  • none
Identifiers
  • 1-(methoxymethyl)-4-oxo-N-propylquinoline-3-carboxamide
CAS Number
  • 113079-82-6 ☒N
PubChem CID
  • 65916
ChemSpider
  • 59325 checkY
UNII
  • 0DH9WUS03O
CompTox Dashboard (EPA)
  • DTXSID50150281 Edit this at Wikidata
Chemical and physical data
FormulaC15H18N2O3
Molar mass274.320 g·mol−1
3D model (JSmol)
  • Interactive image
  • CCCNC(=O)C1=CN(C2=CC=CC=C2C1=O)COC
  • InChI=1S/C15H18N2O3/c1-3-8-16-15(19)12-9-17(10-20-2)13-7-5-4-6-11(13)14(12)18/h4-7,9H,3,8,10H2,1-2H3,(H,16,19) checkY
  • Key:RIPDGZHPNKQLDC-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

See also edit

References edit

  1. ^ Warot D, Danjou P, Douillet P, Keane P, Puech AJ (1994). "Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor". Therapie. 49 (1): 23–6. PMID 8091361.